Seres Therapeutics, Inc. (MCRB)
NASDAQ·Healthcare·Biotechnology
$5.04
-1.18%
Mkt Cap $83.09M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+138.1%
Consensus $12.00 vs current $5.04
NASDAQ·Healthcare·Biotechnology
$5.04
-1.18%
Mkt Cap $83.09M
No recent rating data.
Price Target (2 analysts)
$12.00
Range $12.00 – $12.00
+138.1%
Consensus $12.00 vs current $5.04